Surgical vs Transcatheter Aortic Valve Replacement in Patients With a Low Ejection Fraction
Angiology · 2023-08 · 74 (7) · 664-671
DOI: 10.1177/00033197221121012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiology, online erschienen am 13.08.2022. Verfasst von Amr A Arafat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis, Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Currently, there is no preference for surgical (SAVR) vs transcatheter (TAVR) aortic valve replacement in patients with low ejection fraction (EF). The present study retrospectively compared the outcomes of SAVR vs TAVR in patients with EF ≤40% (70 SAVR and 117 TAVR patients). Study outcomes were survival and the composite endpoint of stroke, aortic valve reintervention, and heart failure readmission. The patients who had TAVR were older (median: 75 (25-75th percentiles: 69-81) vs 51 (39-66) years old; P < .001) with higher EuroSCORE II (4.95 (2.99-9.85) vs 2 (1.5-3.25); P < .001). Postoperative renal impairment was more common with SAVR (8 (12.5%) vs 4 (3.42%); P = .03), and they had longer hospital stay [9 (7-15) vs 4 (2-8) days; P < .001). There was no difference between groups in stroke, reintervention, and readmission (Sub-distributional Hazard ratio: .95 (.37-2.45); P = .92). Survival at 1 and 5 years was 95% and 91% with SAVR and 89% and 63% with TAVR. Adjusted survival was comparable between groups. EF improved significantly (β: .28 (.23-.33); P < 0.001) with no difference between groups ( P = .85). In conclusion, TAVR could be as safe as SAVR in patients with low EF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
- Cardiothoracic Surgery Department, Tanta University, Tanta, Egypt.
- Cardiac Research Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
- Cardiology Clinical Pharmacy Department, Prince Sultan Cardiac Centre, Riyadh, Saudi Arabia.
ORCID-Profile: Amr A Arafat, Monirah A Albabtain
Zitieren
APA
Arafat, A. A., Alawami, M. H., Hassan, E., Alshammari, A., AlFayez, L. A., Albabtain, M. A., Ismail, H. H., Adam, A. I., Pragliola, C., & Algarni, K. D. (2023). Surgical vs Transcatheter Aortic Valve Replacement in Patients With a Low Ejection Fraction. Angiology, 74(7), 664-671. https://doi.org/10.1177/00033197221121012
Vancouver
Arafat AA, Alawami MH, Hassan E, Alshammari A, AlFayez LA, Albabtain MA, et al. Surgical vs Transcatheter Aortic Valve Replacement in Patients With a Low Ejection Fraction. Angiology. 2023;74(7):664-671. doi:10.1177/00033197221121012
BibTeX
@article{Arafat2023,
author = {Arafat, Amr A and Alawami, Murtadha H and Hassan, Essam and Alshammari, Ahmad and AlFayez, Latifa A and Albabtain, Monirah A and Ismail, Huda H and Adam, Adam I and Pragliola, Claudio and Algarni, Khaled D},
title = {Surgical vs Transcatheter Aortic Valve Replacement in Patients With a Low Ejection Fraction},
journal = {Angiology},
year = {2023},
volume = {74},
number = {7},
pages = {664--671},
doi = {10.1177/00033197221121012}
}
EUVIMED